CIK 0001372514 · Non-accelerated filer<br>Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980443284
- Phone
- 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- 4 Grant or award President and CEO acquired 15,941 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,250 shares at $3.68 ($4,600)
- 4 Open-market buy Director bought 3,000 shares at $3.60 ($10,800)
- 4 Open-market buy Director bought 1,250 shares at $3.86 ($4,825)
- 4 Open-market buy Director bought 5,000 shares at $3.96 ($19,800)
- 4 Open-market buy CFO bought 2,000 shares at $3.21 ($6,420)
- 4 Grant or award President and CEO acquired 15,629 shares (grant or award)
- 4 Grant or award CFO acquired 7,620 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Development Officer acquired 7,355 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 21 · 406 filings